Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Cited by (1,020)

Items 201–300 of 1,020

1. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases
   Andrew J. Ullmann, Oliver A. Cornely, J.P. DonneNy, Murat Akova, Maiken Cavling Arendrup, Sevtap Arıkan-Akdağlı, Matteo Bassetti, Jacques Billé, Thierry Calandra, Elio Castagnola et al. · 2012 · Clinical Microbiology and Infection
2. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis
   Hata, Katsura, Horii, Takaaki, Miyazaki, Mamiko, Watanabe, Nao-aki, Okubo, Miyuki, Sonoda, Jiro, Nakamoto, Kazutaka, Tanaka, Keigo, Shirotori, Syuji, Murai, Norio et al. · 2011 · Antimicrobial Agents and Chemotherapy
3. Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance
   Katiyar, Santosh K., Alastruey-Izquierdo, Ana, Healey, Kelley R., Johnson, Michael E., Perlin, David S., Edlind, Thomas D. · 2012 · Antimicrobial Agents and Chemotherapy
4. Recent Developments and Current Issues in the Epidemiology, Diagnosis, and Management of Bacterial and Fungal Neonatal Sepsis
   Barbara J. Stoll, Andi L. Shane · 2013 · American Journal of Perinatology
5. Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
   Mireia Puig‐Asensio, Javier Pemán, Rafael Zaragoza, José Garnacho‐Montero, Estrella Martín‐Mazuelos, Manuel Cuenca‐Estrella, Benito Almirante · 2014 · Critical Care Medicine
6. Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?
   Konstantinos Leventakos, Russell Edward Lewis, Dimitrios P. Kontoyiannis · 2010 · Clinical Infectious Diseases
7. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
   Mahipal Sinnollareddy, Jason Alexander Roberts, Jeffrey Lipman, Murat Akova, Matteo Bassetti, Jan J. De Waele, Kirsi-Maija Kaukonen, Despoina Koulenti, Claude Martin, Philippe Montravers et al. · 2015 · Critical Care
8. Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa
   Nelesh Premapragasan Govender, Jaymati Patel, Rindidzani E. Magobo, Serisha Devi Naicker, Jeannette Wadula, Andrew Christopher Whitelaw, Yacoob Mahomed Coovadia, Ranmini S. Kularatne, Chetna Govind, Shawn R. Lockhart et al. · 2016 · Journal of Antimicrobial Chemotherapy
9. Diagnosis and Management of Fungal Urinary Tract Infection
   Carol A. Kauffman · 2013 · Infectious Disease Clinics of North America
10. Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)
    Oliver A. Cornely, Bertrand Gachot, Hamdi Akan, Matteo Bassetti, Ömrüm Uzun, Christopher C. Kibbler, Oscar Marchetti, Peter de Burghgraeve, Safaa Ramadan, Liisa Pylkkänen et al. · 2015 · Clinical Infectious Diseases
11. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006–2008)
    Anna Maria Tortorano, Giovanna Dho, Anna Prigitano, Giuseppe Breda, Anna Grancini, Vincenzo Emmi, Caterina Cavanna, Giovanni Marino, Silvia Morero, Cristina M. Ossi et al. · 2011 · Mycoses
12. Oral complications in the treatment of cancer patients
    Dd Mosel, RL Bauer, DP Lynch, Samuel T. Hwang · 2011 · Oral Diseases
13. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later
    Philippe Eggimann, Didier Pittet · 2014 · Intensive Care Medicine
14. Oral Candidiasis: Pathogenesis, Clinical Presentation, Diagnosis and Treatment Strategies
    Rajesh V. Lalla, Lauren L. Patton, Anna I. Dongari‐Bagtzoglou · 2013 · Journal of the California Dental Association
15. Injectable in situ cross-linking hydrogels for local antifungal therapy
    Sarah P. Hudson, Róbert Langer, Gerald R. Fink, Daniel S. Kohane · 2009 · Biomaterials
16. Antifungal drugs during pregnancy: an updated review
    B. Pilmis, Vincent Jullien, Jack D. Sobel, Marc Lecuit, Olivier Lortholary, Caroline Charlier · 2014 · Journal of Antimicrobial Chemotherapy
17. Advancements in Regenerative Strategies Through the Continuum of Burn Care
    Randolph Stone, Shanmugasundaram Natesan, Christine J. Kowalczewski, Lauren H. Mangum, Nicholas Edwin Clay, Ryan M. Clohessy, Anders H. Carlsson, David H. Tassin, Rodney K. Chan, Julie A Rizzo et al. · 2018 · Frontiers in Pharmacology
18. Candidosis, a new challenge
    Rubén López‐Martínez · 2010 · Clinics in Dermatology
19. Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008)
    Klingspor, L., Tortorano, A.M., Peman, J., Willinger, B., Hamal, P., Sendid, B., Velegraki, A., Kibbler, C., Meis, J.F., Sabino, R. et al. · 2015 · Clinical Microbiology and Infection
20. Multidrug resistance in fungi: regulation of transporter-encoding gene expression
    Paul, Sanjoy, Moye-Rowley, W. Scott · 2014 · Frontiers in Physiology
21. Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy
    Markus Ruhnke, Volker Rickerts, Oliver A. Cornely, Dieter Buchheidt, Andreas Glöckner, Werner Heinz, Rainer Höhl, R. Horré, Meinolf Karthaus, P. Kujath et al. · 2011 · Mycoses
22. FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
    Zimbeck, Alicia J., Iqbal, Naureen, Ahlquist, Angela M., Farley, Monica M., Harrison, Lee H., Chiller, Tom, Lockhart, Shawn R. · 2010 · Antimicrobial Agents and Chemotherapy
23. Systemic antifungal therapy in critically ill patients without invasive fungal infection*
    Élie Azoulay, Hervé Dupont, Alexis Tabah, Olivier Lortholary, J.‐P. Stahl, Adrien Français, Claude Martin, Bertand Guidet, JF Timsit · 2012 · Critical Care Medicine
24. Small Intestinal Fungal Overgrowth
    Aşkın Erdoğan, Satish S.C. Rao · 2015 · Current Gastroenterology Reports
25. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
    Danièle Maubon, Cécile Garnaud, Thierry Calandra, Dominique Sanglard, Muriel Cornet · 2014 · Intensive Care Medicine
26. Antifungal lock therapy
    Walraven, Carla J., Lee, Samuel A. · 2013 · Antimicrobial Agents and Chemotherapy
27. Insights into Candida tropicalis nosocomial infections and virulence factors
    Negri, M., Silva, S., Henriques, M., Oliveira, R. · 2012 · European Journal of Clinical Microbiology & Infectious Diseases
28. Effect of Fluconazole Prophylaxis on Candidiasis and Mortality in Premature Infants
    Daniel K. Benjamin, Mark Lawrence Hudak, Shahnaz Duara, David A. Randolph, Margarita Bidegain, Gratias T. Mundakel, Girija Natarajan, David J. Burchfield, Robert D. White, Karen E. Shattuck et al. · 2014 · JAMA
29. A review of Candida species causing blood stream infection
    Sidhartha Giri, Anupama Jyoti Kindo · 2012 · Indian Journal of Medical Microbiology
30. The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps
    Chad J Johnson, Jonathan Cabezas‐Olcoz, John F. Kernien, Steven X. Wang, David J. Beebe, Anna Huttenlocher, Hamayail Ansari, Jeniel E. Nett · 2016 · PLoS Pathogens
31. Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications
    Forastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I. et al. · 2013 · Antimicrobial Agents and Chemotherapy
32. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections
    Jesse W.P. Kuiper, Michel P.J. van den Bekerom, Jurgen van der Stappen, Peter A. Nolte, Sascha Colen · 2013 · Acta Orthopaedica
33. Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
    Jodi M. Lestner, William W. Hope · 2013 · Expert Opinion on Drug Metabolism & Toxicology
34. Diagnosis of invasive candidiasis in the ICU
    Philippe Eggimann, Jacques Billé, Oscar Marchetti · 2011 · Annals of Intensive Care
35. T cells from patients with Candida sepsis display a suppressive immunophenotype
    Andrej Spec, Yuichiro Shindo, Carey‐Ann D. Burnham, Strother Wilson, Enyo Ablordeppey, Evan R. Beiter, Katherine C. Chang, Anne M. Drewry, Richard S. Hotchkiss · 2016 · Critical Care
36. The risk and clinical outcome of candidemia depending on underlying malignancy
    The French Mycoses Study Group, Olivier Lortholary, Charlotte Renaudat, Karine Sitbon, Marie Desnos‐Ollivier, Stéphane Bretagne, Françoise Dromer · 2017 · Intensive Care Medicine
37. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
    Pfaller, Michael A., Andes, David, Arendrup, Maiken C., Diekema, Daniel J., Espinel-Ingroff, Ana, Alexander, Barbara D., Brown, Steven D., Chaturvedi, Vishnu, Fowler, Cynthia L., Ghannoum, Mahmoud A. et al. · 2011 · Diagnostic Microbiology and Infectious Disease
38. Candida spp. with Acquired Echinocandin Resistance, France, 2004–20101
    Dannaoui, Eric, Desnos-Ollivier, Marie, Garcia-Hermoso, Dea, Grenouillet, Fredéric, Cassaing, Sophie, Baixench, Marie-Thérèse, Bretagne, Stéphane, Dromer, Françoise, Lortholary, Olivier, the French Mycoses Study Group · 2012 · Emerging infectious diseases
39. Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
    Arendrup, Maiken C., Cuenca-Estrella, Manuel, Lass-Flörl, Cornelia, Hope, William W. · 2013 · Drug Resistance Updates
40. Probiotics for vulvovaginal candidiasis in non-pregnant women
    Xie, Huan Yu, Feng, Dan, Wei, Dong Mei, Mei, Ling, Chen, Hui, Wang, Xun, Fang, Fang · 2017 · Cochrane Database of Systematic Reviews
41. Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011
    Jesús Guinea, Óscar Zaragoza, Pilar Escribano, Estrella Martín‐Mazuelos, Javier Pemán, F Sánchez, Manuel Cuenca‐Estrella · 2013 · Antimicrobial Agents and Chemotherapy
42. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections
    Anup Kumar Ghosh, Saikat Paul, Prashant Sood, Shivaprakash Mandya Rudramurthy, A. Rajbanshi, T.J. Jillwin, Arunaloke Chakrabarti · 2014 · Clinical Microbiology and Infection
43. Risk Factors for Fluconazole-Resistant Candidemia
    José Garnacho‐Montero, Ana Díaz‐Martín, Emilio García-Cabrera, Maite Ruiz Pérez de Pipaón, C Hernandez-Caballero, Javier Aznar, José Miguel Cisneros, Carlos Ortíz-Leyba · 2010 · Antimicrobial Agents and Chemotherapy
44. Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection
    Michelle M. Nerandzic, Kathleen M. Mullane, Mark A. Miller, Farah Babakhani, Curtis J. Donskey · 2012 · Clinical Infectious Diseases
45. The case for antifungal stewardship
    Michelle R. Ananda-Rajah, Monica A. Slavin, Karin Thursky · 2011 · Current Opinion in Infectious Diseases
46. Variation in Susceptibility of Bloodstream Isolates ofCandida glabratato Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007
    Michael A. Pfaller, Shawn A. Messer, Richard J. Hollis, Linda B. Boyken, Shailesh Tendolkar, Jennifer S. Kroeger, Daniel J. Diekema · 2009 · Journal of Clinical Microbiology
47. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species
    Michael A. Pfaller, Mariana Castanheira, Daniel J. Diekema, Shawn A. Messer, Gary J. Moet, Ronald N. Jones · 2010 · Journal of Clinical Microbiology
48. Diagnosis, management and outcome of Candida endocarditis
    Agnès Lefort, Loïc Chartier, Boualem Sendid, Michel Wolff, Jean‐Luc Mainardi, Isabelle Podglajen, Marie Desnos‐Ollivier, Arnaud L Fontanet, Stéphane Bretagne, Olivier Lortholary · 2012 · Clinical Microbiology and Infection
49. Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA
    Samuel Aballéa, Florent Guelfucci, Julian Wagner, Amine Khemiri, Jean-Paul Dietz, Jack D. Sobel, Mondher Toumi · 2013 · Health and Quality of Life Outcomes
50. Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed
    Maricela Valerio, Carmen Guadalupe Rodríguez-González, P. Munoz, B. Caliz, María Sanjurjo‐Sáez, Emilio Bouza, on behalf of the COMIC Study Group (Collaborative Group on Mycoses), F. Anaya, Rafael Bañares, Emilio Bouza et al. · 2014 · Journal of Antimicrobial Chemotherapy
51. A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis
    Lin Jin, Xuewei Bai, Ning Luan, Huimin Yao, Zhiye Zhang, Weihui Liu, Yan Chen, Xiuwen Yan, Mingqiang Rong, Ren Lai et al. · 2016 · Journal of Medicinal Chemistry
52. Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
    Voon S. Ong, Grayson Hough, Michael Schlosser, Ken F. Bartizal, James M. Balkovec, Kenneth D. James, B Radha Krishnan · 2016 · Antimicrobial Agents and Chemotherapy
53. Candida tropicalisin human disease
    Louis Yi Ann Chai, David W. Denning, Peter A. Warn · 2010 · Critical Reviews in Microbiology
54. Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern
    Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L. et al. · 2018 · Journal of Clinical Microbiology
55. In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of RareCandidaSpecies as Determined by CLSI Broth Microdilution Methods
    Daniel J. Diekema, Shawn A. Messer, Linda B. Boyken, Richard J. Hollis, Jennifer S. Kroeger, Shailesh Tendolkar, Michael A. Pfaller · 2009 · Journal of Clinical Microbiology
56. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
    Mitsutoshi Kurosawa, Masakatsu Yonezumi, Satoshi Hashino, Junji Tanaka, Mitsufumi Nishio, Makoto Kaneda, Shuichi Ota, Kyuhei Koda, Nobuhiro Suzuki, Makoto Yoshida et al. · 2012 · International Journal of Hematology
57. Diagnosis of invasive fungal infections in hematology and oncology—guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)
    Markus Ruhnke, Angelika Böhme, Dieter Buchheidt, Oliver A. Cornely, Konrad Donhuijsen, Hermann Einsele, R Enzensberger, Holger Frithjof Hebart, Claus Peter Heußel, Marius Horger et al. · 2011 · Annals of Oncology
58. Diagnosis and Treatment of Esophageal Candidiasis: Current Updates
    Abdimajid Ahmed Mohamed, Xinliang Lu, Faycal Awaleh Moumin · 2019 · Canadian Journal of Gastroenterology and Hepatology
59. Antifungal stewardship in a tertiary-care institution: a bedside intervention
    Maricela Valerio, Patricia Muñóz, C.G. Rodríguez, B. Caliz, B. Padilla, Ana Fernández‐Cruz, M. Sánchez-Somolinos, Paloma Gijón, J Del Castillo Peral, Jorge Gayoso et al. · 2015 · Clinical Microbiology and Infection
60. The Epidemiology and Diagnosis of Invasive Candidiasis Among Premature Infants
    Matthew S. Kelly, Daniel Kelly Benjamin, P. Brian Smith · 2014 · Clinics in Perinatology
61. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance
    Meng Xiao, Xin Fan, Sharon C.‐A. Chen, He Wang, Ziyong Sun, Kang Liao, Shu-Lan Chen, Yan Yan, Mei Kang, Zhi-Dong Hu et al. · 2014 · Journal of Antimicrobial Chemotherapy
62. Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
    Ľuboš Drgoňa, Alexandra Khachatryan, Jennifer Stephens, Claudie Charbonneau, Michal Kantecki, Sajjad Haider, Rosemary A. Barnes · 2013 · European Journal of Clinical Microbiology & Infectious Diseases
63. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: A propensity score analysis
    Fernández-Ruiz, Mario, Aguado, José María, Almirante, Benito, Lora-Pablos, David, Padilla, Belén, Puig-Asensio, Mireia, Montejo, Miguel, García-Rodríguez, Julio, Pemán, Javier, Ruiz Pérez de Pipaón, Maite et al. · 2014 · Clinical Infectious Diseases
64. Early State Research on Antifungal Natural Products
    Melyssa Negri, Tânia Pereira Salci, Cristiane Suemi Shinobu Mesquita, Isis Regina Grenier Capoci, Terezinha Inez Estivalet Svidzinski, Érika Seki Kioshima · 2014 · Molecules
65. Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
    Cristina Jiménez‐Ortigosa, Padmaja Paderu, Mary R. Motyl, David S. Perlin · 2013 · Antimicrobial Agents and Chemotherapy
66. Candidiasis: A Fungal Infection- Current Challenges and Progress in Prevention and Treatment
    Umme Hani, Hosakote Gurumallappa Shivakumar, Rudra Vaghela, Riyaz Ali M. Osmani, Atul Shrivastava · 2015 · Infectious Disorders - Drug Targets
67. Prevalence, Distribution, and Antifungal Susceptibility Profiles of Candida parapsilosis , C. orthopsilosis , and C. metapsilosis in a Tertiary Care Hospital
    Ana P. Silva, Isabel Marcos Miranda, Cármen Lisboa, Cidália Pina‐Vaz, Acácio Gonçalves Rodrigues · 2009 · Journal of Clinical Microbiology
68. Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
    Souza, Ana Carolina R., Fuchs, Beth Burgwyn, Pinhati, Henrique M. S., Siqueira, Ricardo A., Hagen, Ferry, Meis, Jacques F., Mylonakis, Eleftherios, Colombo, Arnaldo L. · 2015 · Antimicrobial Agents and Chemotherapy
69. β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
    Kimberly E. Hanson, Christopher D. Pfeiffer, Erika D. Lease, Alfred H. Balch, Aimee K. Zaas, John R. Perfect, Barbara Dudley Alexander · 2012 · PLoS ONE
70. Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia
    David R. Andes, Paul G. Ambrose, Jeffrey Hammel, Scott A. Van Wart, Varsha Iyer, Daniel K. Reynolds, Donald N. Buell, Laura Lynn Kovanda, Sujata M. Bhavnani · 2011 · Antimicrobial Agents and Chemotherapy
71. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes
    Shellee A. Grim, Karen Berger, Christine B. Teng, S. Gupta, Jennifer E. Layden, William M. Janda, Nina M. Clark · 2011 · Journal of Antimicrobial Chemotherapy
72. Oral Candidosis: Pathophysiology and Best Practice for Diagnosis, Classification, and Successful Management
    Lu, Shin-Yu · 2021 · Journal of Fungi
73. Invasive Fungal Infections in Patients with Chronic Granulomatous Disease
    Stefanie Henriet, Paul E. Verweij, Steven M. Holland, Adilia Warris · 2012 · Advances in experimental medicine and biology
74. Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations
    Arendrup, Maiken Cavling, Perlin, David S., Jensen, Rasmus Hare, Howard, Susan Julie, Goodwin, Joanne, Hope, William · 2012 · Antimicrobial Agents and Chemotherapy
75. Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
    Lauren Piper, P. Brian Smith, Christoph Paul Vincent Hornik, Ira M. Cheifetz, Jeffrey S. Barrett, Ganesh Moorthy, William W. Hope, Kelly Cant Wade, Michael Cohen‐Wolkowiez, Daniel Kelly Benjamin · 2010 · The Pediatric Infectious Disease Journal
76. Population Pharmacokinetics of Voriconazole in Adults
    William W. Hope · 2011 · Antimicrobial Agents and Chemotherapy
77. Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines
    Abdur Rahman Khan, Sobia Khan, Valerie A. Zimmerman, Larry M. Baddour, Imad M. Tleyjeh · 2010 · Clinical Infectious Diseases
78. Oral candidiasis and angular cheilitis
    Victoria R. Sharon, Nasim Fazel · 2010 · Dermatologic Therapy
79. The role of gut mycobiome in health and diseases
    Lin Zhang, Hui Zhan, Wenye Xu, Shuai Yan, Siew C. Ng · 2021 · Therapeutic Advances in Gastroenterology
80. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections
    José Garnacho‐Montero, Ana Díaz‐Martín, Emilio García-Cabrera, Maite Ruiz Pérez de Pipaón, C Hernandez-Caballero, José Antonio Lepe · 2012 · Journal of Antimicrobial Chemotherapy
81. Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients
    D. J. Winston, Ajit P. Limaye, Shawn J. Pelletier, Nasia Safdar, Michele Ileana Morris, Katherine G. Meneses, Ronald W. Busuttil, Navreet Singh · 2014 · American Journal of Transplantation
82. Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system
    Grossman, Nina T., Pham, Cau D., Cleveland, Angela A., Lockhart, Shawn R. · 2015 · Antimicrobial Agents and Chemotherapy
83. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies
    Gamaletsou, M.N., Walsh, T.J., Zaoutis, T., Pagoni, M., Kotsopoulou, M., Voulgarelis, M., Panayiotidis, P., Vassilakopoulos, T., Angelopoulou, M.K., Marangos, M. et al. · 2014 · Clinical Microbiology and Infection
84. Improved Identification of Yeast Species Directly from Positive Blood Culture Media by Combining Sepsityper Specimen Processing and Microflex Analysis with the Matrix-Assisted Laser Desorption Ionization Biotyper System
    Yingjun Yan, Ying He, Thomas H. P. Maier, Criziel D. Quinn, Gongyi Shi, Haijing Li, Charles W. Stratton, Markus Kostrzewa, Yi‐Wei Tang · 2011 · Journal of Clinical Microbiology
85. Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study
    Lyon, G. Marshall, Karatela, Sulaiman, Sunay, Susan, Adiri, Yaffa · 2010 · Journal of Clinical Microbiology
86. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
    George Kelly Siberry, Mark J. Abzug, Sharon Nachman, Michael T. Brady, Kenneth L. Dominguez, Edward L. Handelsman, LYNNE M. MOFENSON, Steven R. Nesheim · 2013 · The Pediatric Infectious Disease Journal
87. Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era
    Faouzi Saliba, Valerie Delvart, Philippe Ichaı̈, Najiby Kassis, Françoise Botterel, Liliana Mihaïla-Amrouche, Daniel Azoulay, René A. Adam, Denis Castaing, Stéphane Bretagne et al. · 2013 · Clinical Transplantation
88. New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis
    Blandine Rammaert, A. Desjardins, Olivier Lortholary · 2012 · Mycoses
89. Echinocandins: production and applications
    Tamás Emri, László Majoros, Viktória Tóth, István Pócsi · 2013 · Applied Microbiology and Biotechnology
90. Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches
    Beyda, Nicholas D, Lewis, Russell E, Garey, Kevin W · 2012 · Annals of Pharmacotherapy
91. In vitro activity of antifungal combinations against Candida albicans biofilms
    Selma Tobudic, Christina Kratzer, Andrea M. Lassnigg, Winfried B. Graninger, Elisabeth Presterl · 2009 · Journal of Antimicrobial Chemotherapy
92. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China
    Zengli Xiao, Qi Wang, Fengxue Zhu, Youzhong An · 2019 · Antimicrobial Resistance and Infection Control
93. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics
    Gianluca Ianiro, Rita Murri, Giusi Desirè Sciumè, Michele Impagnatiello, Luca Masucci, Alexander Charles Ford, Graham Richard Law, Herbert Tilg, Maurizio Sanguinetti, Roberto Cauda et al. · 2019 · Annals of Internal Medicine
94. The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
    Pei Yee Tiew, Micheál Mac Aogáin, Nur A’tikah Binte Mohamed Ali, Kai Xian Thng, Karlyn Goh, Kenny J. X. Lau, Sanjay Haresh Chotirmall · 2020 · Mycopathologia
95. Time to positive culture and identification for Candida blood stream infections
    Fernandez, Julianna, Erstad, Brian L., Petty, Wanda, Nix, David E. · 2009 · Diagnostic Microbiology and Infectious Disease
96. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.
    Shields, Ryan K., Nguyen, M. Hong, Press, Ellen G., Updike, Cassaundra L., Clancy, Cornelius J. · 2013 · Antimicrobial Agents and Chemotherapy
97. Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole
    Espinel-Ingroff, A., Pfaller, M. A., Bustamante, B., Canton, E., Fothergill, A., Fuller, J., Gonzalez, G. M., Lass-Flörl, C., Lockhart, S. R., Martin-Mazuelos, E. et al. · 2014 · Antimicrobial Agents and Chemotherapy
98. What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients
    Cristóbal León, Luis L. Ostrosky-Zeichner, Mindy G. Schuster · 2014 · Intensive Care Medicine
99. In VitroSusceptibilities of Yeast Species to Fluconazole and Voriconazole as Determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study
    He Wang, Meng Xiao, Sharon C.-A. Chen, Fanrong Kong, Ziyong Sun, Kang Liao, Juan Lü, Haifeng Shao, Yan Yan, Hong Song Fan et al. · 2012 · Journal of Clinical Microbiology
100. Candida Infections in Solid Organ Transplantation
     Fernanda P. Silveira, Shimon Kusne · 2013 · American Journal of Transplantation